The in vitro effects of isoprinosine (ISO) on interleukin-2 (IL-2) production, the expression of Tac antigen (IL-2 receptor) on lymphocytes, and the ability of Leu 3(+) cells to absorb interleukin-1 (IL-1) were investigated in 10 patients with acquired immune deficiency syndrome (AIDS). In 9 of the 10 patients, production of IL-2 from mononuclear cells and Leu 3(+) cells was depressed; expression of Tac antigen on mononuclear cells and Leu 2(+) cells was found to be depressed in 9 of 10 patients. The ability of the Leu 3(+) lymphocytes to absorb IL-1 was depressed in all (four of four) patients studied. After ISO treatment, IL-2 production, Tac antigen expression and IL-i absorption were restored to normal or near normal levels in most of the patients. These results suggest that ISO has an immunostimulating capacity in AIDS patients and that the potential of ISO in immune response restoration in AIDS patients deserves critical consideration.
Introduction
Acquired immune deficiency syndrome (AIDS)' is characterized by severe defects in immune responses, e.g., markedly depleted helper T cells (1, 2) , impaired natural killer cell (NK) activity (3, 4) , inverted helper/suppressor cell ratio (5, 6) , depressed responses to mitogens and alloantigens (7) , and depressed interleukin-2 (IL-2) production (8, 9) . Although the etiology of AIDS is unknown, recent evidence suggests that retroviruses (HTLV-III) may be implicated as the primary cause of AIDS (10) (11) (12) (13) . It has been shown that IL-2 augments NK activity both in animals and in humans (14) (15) (16) . Rook et al. (16) reported that IL-2 enhanced the depressed NK activity and cytomegalovirus-specific cytotoxic activity of lymphocytes from AIDS patients in vitro. Furthermore, NK activity and lymphocyte-proliferative activity were partly reconstituted when AIDS patients were treated with human recombinant IL-2 (9) . This is Publication No. 712 from the Department of Basic and Clinical Immunology and Microbiology, Medical University of South Carolina.
Received for publication 21 September 1984 and in revised form 11 January 1985. Isoprinosine (ISO) is an immune-potentiating drug demonstrated to augment NK activity in humans and animals (17) (18) (19) . It can also enhance IL-2 production in mitogenstimulated human lymphocytes in vitro (20) . The rationale of IL-2 trials in AIDS patients at the National Institutes of Health (21) was based on the fact that IL-2 can augment both NK activity and cytotoxic T cell activity in these patients. We T cell subset isolation. T lymphocytes were separated by using nonadherent mononuclear cells resettled with 2-aminoethylisothiouronium bromide hydrobromide-treated sheep erythrocytes and then followed by lysis of the attached erythrocytes with 0.85% Tris-buffered NH4Cl solution.
Leu 2(+) and Leu 3(+) lymphocytes were isolated by the elimination method described by Timonen et al. (25) . In brief, 0.2 ml of a 1:10 dilution of anti-Leu 2 or anti-Leu 3 antibodies was added to 5 X 106 lymphocytes in 0.1 ml of medium. The mixture was kept on ice for 30 min before addition of 1 ml of a 1:10 dilution of guinea pig complement. After further incubation for 60 min at 370C, the cells were washed and resuspended at 1 X 106 cells/ml in RPMI-1640 containing 5% fetal bovine serum. The efficiency of the procedure in removing cells was checked by staining the remaining lymphocytes with anti-Leu 2 and anti-Leu 3 antibodies.
Interleukin-J (IL-J) activity assay. IL-l was prepared by stimulation of normal human monocytes by the method similar to Gery et al.
(26). Monocytes (106 cell/ml) were cultured with lipopolysaccharide (5 gg/ml) for 48 h at 37°C and then dialyzed for 24 h against RPMI-1640 medium. For absorption studies, 106 Leu 3(+) cells were added to IL-1 preparations in the presence or absence of PHA and incubated for 24 h at 37°C. The supernatants were recovered by centrifugation and partially purified by Sephadex G-100 column chromatography to remove the PHA in the supernatant and then concentrated to the original volume. IL-1 activity was assayed by the method described by Simons et al. (27, 28 Effects ofisoprinosine on IL-2 production. Table  II shows the production of IL-2 by Leu 3(+) T cells in patients and normal controls as well as the effect of ISO on IL-2 production of Leu 3(+) T cells. IL-2 production was significantly increased after treatment with ISO in both normals and patients (except patient 6). ISO effects on Tac antigen expression. Fig. 4 increases in the percentage of Tac(+) cells were observed in nine patients with AIDS with the exception of patient 6. Table  IV shows the effects of ISO on Tac antigen expression on Leu 2(+) T lymphocytes in AIDS patients.
Effect ofISO on IL-I absorption. Table V shows the effect of ISO on IL-l absorption by Leu 3(+) T lymphocytes in four 
